Edge Advisors’s ResMed RMD Stock Holding History

Edge Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$36K	Hold	349	–	–	﹤0.01%	558
2018 Q1	$34K	Hold	349	–	–	﹤0.01%	574
2017 Q4	$29K	Buy	349 +343	+5,717%	+$28.3K	﹤0.01%	624
2017 Q3	$0	Buy	+6	New	+$459	﹤0.01%	975

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edge Advisors's RMD Position: Q2 2018 in Review

Edge Advisors held its ResMed (RMD) position steady in Q2 2018 at 349 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #558.

Edge Advisors first reported a position in RMD in Q3 2017 and has held it in 4 quarters since. 465 funds tracked by Wall St. Rank hold RMD as of Q2 2018.

Edge Advisors held 349 shares of ResMed worth $36K as of Q2 2018.
Edge Advisors left its ResMed share count unchanged in Q2 2018.
ResMed made up ﹤0.01% of Edge Advisors's portfolio in Q2 2018, its #558 holding.
Edge Advisors first reported a position in ResMed in Q3 2017 and has held it in 4 quarters since.
465 funds tracked by Wall St. Rank held ResMed as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.